Table 1. Total number of dispensed prescriptions through U.S. outpatient retail pharmacies for selected opioid pain agents by product form, January 1, 2006 - December 31, 2008 RtaiRSreRetai RSareRtailRxSre2220 N
| %
| N
| %
| N
| %
| ||||||
TOTAL MARKET
| 179,690,966
| 100.0%
| 192,502,779
| 100.0%
| 201,757,684
| 100.0%
| |||||
Immediate Release
| 164,246,443
| 91.4%
| 175,377,090
| 91.1%
| 183,332,224
| 90.9%
| |||||
hydrocodone
| 111,750,006
| 68.0%
| 118,944,252
| 67.8%
| 122,736,942
| 66.9%
| |||||
oxycodone
| 30,668,659
| 18.7%
| 34,668,180
| 19.8%
| 38,895,131
| 21.2%
| |||||
codeine
| 14,966,588
| 9.1%
| 14,254,899
| 8.1%
| 13,554,150
| 7.4%
| |||||
methadone
| 3,913,044
| 2.4%
| 4,181,652
| 2.4%
| 4,439,950
| 2.4%
| |||||
hydromorphone
| 1,388,900
| 0.8%
| 1,617,911
| 0.9%
| 1,868,423
| 1.0%
| |||||
morphine
| 1,191,911
| 0.7%
| 1,303,570
| 0.7%
| 1,427,835
| 0.8%
| |||||
fentanyl
| 359,106
| 0.2%
| 344,667
| 0.2%
| 300,840
| 0.2%
| |||||
oxymorphone
| 8,229
| 0.0%
| 61,959
| 0.0%
| 108,953
| 0.1%
| |||||
Extended Release
| 15,444,523
| 8.6%
| 17,125,689
| 8.9%
| 18,425,460
| 9.1%
| |||||
oxycodone
| 6,960,034
| 45.1%
| 7,541,029
| 44.0%
| 7,816,692
| 42.4%
| |||||
fentanyl
| 4,734,610
| 30.7%
| 5,195,507
| 30.3%
| 5,378,501
| 29.2%
| |||||
morphine
| 3,729,690
| 24.1%
| 4,194,878
| 24.5%
| 4,830,702
| 26.2%
| |||||
oxymorphone
| 20,172
| 0.1%
| 194,274
| 1.1%
| 399,565
| 2.2%
| |||||
hydromorphone
| 17
| 0.0%
| 1
| 0.0%
| -
| -
| |||||
Source: SDI Vector One®: National, Data Extracted 8-2009. File: VONA 2009-970 selected opioids form 08-18-09.xls
| |||||||||||
November 2, 2009 - 1:27am

Thanks for the eye-opener, Saturated . . . Q